Historic Boston plays host to the fifth Tecan Symposium
11 December 2012 | By kdm communications limited
Tecan recently hosted the fifth annual Tecan Symposium in the picturesque surroundings of Boston, Massachusetts...
List view / Grid view
11 December 2012 | By kdm communications limited
Tecan recently hosted the fifth annual Tecan Symposium in the picturesque surroundings of Boston, Massachusetts...
11 December 2012 | By Novartis
Novartis announced long-term follow-up data...
11 December 2012 | By Boehringer Ingelheim
Boehringer Ingelheim’s Metacam® has obtained EU wide marketing authorizations...
10 December 2012 | By Red Consultancy
Results from a completed phase II study...
10 December 2012 | By GlaxoSmithKline
Partnership aims to create sustainable and scalable model to be replicated across Africa...
10 December 2012 | By Boehringer Ingelheim
Results from a new post-hoc analysis...
10 December 2012 | By Amgen
Amgen and deCODE Genetics announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics...
10 December 2012 | By Boehringer Ingelheim
New positive Phase II results...
10 December 2012 | By Gilead Sciences
Gilead Sciences, Inc. announced that its Board of Directors has approved a two-for-one stock split...
10 December 2012 | By Novartis
Latest results from two Phase III clinical trials...
9 December 2012 | By Bristol-Myers Squibb Company
Results from Phase 2 open-label study...
9 December 2012 | By Sanofi
New data presented at American Society of Hematology Annual Meeting show activity against disease and symptom alleviation...
8 December 2012 | By Roche
Roche announced results from two studies...
8 December 2012 | By Roche
Roche announced updated survival results from the Phase III CLEOPATRA study...
8 December 2012 | By Bristol-Myers Squibb Company
Results of the Phase 3 AMPLIFY-EXT trial...